ARDS - Aridis Pharma has 67% upside - Wainwright December, 30 2019 07:38 AM Aridis Pharmaceuticals Inc. Wainright analyst Vernon Bernardino starts Aridis Pharma (NASDAQ:ARDS) at Buy with a $7 price target, implying 67% upside.More news on: Aridis Pharmaceuticals, Inc., , Healthcare stocks news, Read more ...